Future Science Group
Browse
0308 Suppl.docx (69.07 kB)

Supplementary Tables – Incidence of safety events after immune checkpoint inhibitor initiation for advanced-stage non-small-cell lung cancer: a real-world study

Download (69.07 kB)
dataset
posted on 2022-07-18, 08:47 authored by Taylor & FrancisTaylor & Francis, Daniel C Beachler, Francois Xavier Lamy, Francesca Kolitsopoulos, Jade Dinh, Anahit Papazian, Aziza Jamal-Allial, Seyed Hamidreza Mahmoudpour, Elisabete Michelon, Patrice Verpillat

  

Supplemental Table 1: Code lists for safety event algorithms

  

Supplemental Table 2. Incidence of safety events by case definition in the overall cohort (n=44,045)


Supplemental Table 3: Incidence of safety events by case definition before and after the start of ICIs in the advanced-stage NSCLC cohort

  

Supplemental Table 4: Incidence of selected safety events in the first 6 months and after 6 months of ICIs in the advanced-stage NSCLC cohort (N=5,278)

Funding

Merck (CrossRef Funder ID: 10.13039/100009945)

History

Usage metrics

    Future Oncology

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC